CVE-2022-48226
HIGHCVSS 7.8/10EPSS 0.18%
Last modified
CVE-2022-48226 is a high-severity vulnerability rated 7.8/10 on the CVSS scale. An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. During installation, an EXE gets executed out of C:\Windows\Temp. EPSS estimates a 0.18% chance of exploitation in the next 30 days.
Description
An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. During installation, an EXE gets executed out of C:\Windows\Temp. A standard user can create the path file ahead of time and obtain elevated code execution. Permissions need to be modified to prevent manipulation.
Metrics
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Gbgplc | Acuant Acufill Sdk | < 10.22.02.03 |
References
- https://acuant.comNot Applicable
- https://hackandpwn.com/disclosures/CVE-2022-48226.pdfThird Party Advisory
- https://acuant.comNot Applicable
- https://hackandpwn.com/disclosures/CVE-2022-48226.pdfThird Party Advisory
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2022-48226?
An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. During installation, an EXE gets executed out of C:\Windows\Temp. A standard user can create the path file ahead of time and obtain elevated code execution. Permissions need to be modified to prevent manipulation.
How severe is CVE-2022-48226?
CVE-2022-48226 has a CVSS score of 7.8/10 (HIGH severity). The EPSS model estimates a 0.18% probability of exploitation in the next 30 days.
How do I fix CVE-2022-48226?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.
Are you affected by CVE-2022-48226?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST